Combinations Of A 4-Pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases
Patent No. EP3658140 (titled "Combinations Of A 4-Pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases") was filed by Idorsia Pharmaceuticals on Nov 6, 2017. The application was issued on May 21, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3658140
- Application Number
- EP17794712A
- Filing Date
- Nov 6, 2017
- Status
- Granted And Under Opposition
- Apr 18, 2025
- Publication Date
- May 21, 2025
- External Links
- Slate, Register , Google Patents